search
Back to results

STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.

Primary Purpose

Chronic Periodontitis

Status
Unknown status
Phase
Not Applicable
Locations
Colombia
Study Type
Interventional
Intervention
Scaling and root planing plus Azithromycin
Scaling and root planing plus placebo
Sponsored by
Universidad del Valle, Colombia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Periodontitis

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • must be of legal age (≥ 18 years old)
  • voluntary participation and signed information consent
  • confirmed systemically healthy individual
  • at least 15 teeth present in mouth

Exclusion Criteria

  • pregnant women
  • smokers
  • antibiotic consumption 6 months before inclusion
  • HIV positive or AIDS
  • Allergic reactions to macrolides and specifically to azithromycin
  • Periodontal treatment 6 months before inclusion

Sites / Locations

  • Universidad Del Valle

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Placebo Comparator

No Intervention

Arm Label

Scaling and root planing plus Azithromycin

Scaling and root planing plus placebo

baselline screening only

Arm Description

Single session of scaling and root planning. Azithromycin tablets 500mg, 1 tablet every 24 hours for 5 days

Single session of scaling and root planning placebo tablets 500mg, 1 tablet every 24 hours for 3 days

Dental prophylaxis is offered

Outcomes

Primary Outcome Measures

EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN.
High sensitive C reactive protein - hs-PCR levels evaluate the effect of periodontal therapy alone or with azithromycin on levels of high sensitivity C-reactive protein (hs CRP) in patients with chronic periodontitis

Secondary Outcome Measures

STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER LIPIDIC PROFILE
evaluate the effect of periodontal therapy alone or with azithromycin on levels of profile lipidic (Total cholesterol, triglycerides, HDL, LDL) in patients with chronic periodontitis
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER GLYCEMIA LEVELS
evaluate the effect of periodontal therapy alone or with azithromycin on levels of glycemia in patients with chronic periodontitis
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER BLOOD BIOCHEMISTRY
evaluate the effect of periodontal therapy alone or with azithromycin on blood biochemistry (arterial index, hemogram) in patients with chronic periodontitis.

Full Information

First Posted
May 23, 2013
Last Updated
July 19, 2013
Sponsor
Universidad del Valle, Colombia
search

1. Study Identification

Unique Protocol Identification Number
NCT01906450
Brief Title
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.
Official Title
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.
Study Type
Interventional

2. Study Status

Record Verification Date
July 2013
Overall Recruitment Status
Unknown status
Study Start Date
May 2013 (undefined)
Primary Completion Date
September 2013 (Anticipated)
Study Completion Date
January 2014 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universidad del Valle, Colombia

4. Oversight

5. Study Description

Brief Summary
Human periodontitis is a group of highly prevalent oral inflammatory diseases and infections with relatively easy treatment and preventive features. The present study is aimed to determine if treating human individuals with chronic periodontitis, along with the use of antibiotics, reduces cardiovascular risk marker (HsPCR) and also intends to identify if severity of periodontitis could be associated with a raise of systemic inflammatory biomarkers on baseline.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Periodontitis

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
75 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Scaling and root planing plus Azithromycin
Arm Type
Experimental
Arm Description
Single session of scaling and root planning. Azithromycin tablets 500mg, 1 tablet every 24 hours for 5 days
Arm Title
Scaling and root planing plus placebo
Arm Type
Placebo Comparator
Arm Description
Single session of scaling and root planning placebo tablets 500mg, 1 tablet every 24 hours for 3 days
Arm Title
baselline screening only
Arm Type
No Intervention
Arm Description
Dental prophylaxis is offered
Intervention Type
Drug
Intervention Name(s)
Scaling and root planing plus Azithromycin
Intervention Description
Single session of scaling and root planning using ultrasonic device. Azithromycin tablets 500mg, 1 tablet every 24 hours for 5 days
Intervention Type
Drug
Intervention Name(s)
Scaling and root planing plus placebo
Intervention Description
Single session of scaling and root planning placebo tablets 500mg, 1 tablet every 24 hours for 3 days
Primary Outcome Measure Information:
Title
EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN.
Description
High sensitive C reactive protein - hs-PCR levels evaluate the effect of periodontal therapy alone or with azithromycin on levels of high sensitivity C-reactive protein (hs CRP) in patients with chronic periodontitis
Time Frame
3 months
Secondary Outcome Measure Information:
Title
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER LIPIDIC PROFILE
Description
evaluate the effect of periodontal therapy alone or with azithromycin on levels of profile lipidic (Total cholesterol, triglycerides, HDL, LDL) in patients with chronic periodontitis
Time Frame
3 months
Title
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER GLYCEMIA LEVELS
Description
evaluate the effect of periodontal therapy alone or with azithromycin on levels of glycemia in patients with chronic periodontitis
Time Frame
3 months
Title
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER BLOOD BIOCHEMISTRY
Description
evaluate the effect of periodontal therapy alone or with azithromycin on blood biochemistry (arterial index, hemogram) in patients with chronic periodontitis.
Time Frame
3 MONTHS
Other Pre-specified Outcome Measures:
Title
STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER PERIODONTAL PARAMETERS
Description
evaluate the effect of periodontal therapy alone or with azithromycin on periodontal parameters (probing deep, bleeding on probing, clinical atachment level) in patients with chronic periodontitis.
Time Frame
3 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: must be of legal age (≥ 18 years old) voluntary participation and signed information consent confirmed systemically healthy individual at least 15 teeth present in mouth Exclusion Criteria pregnant women smokers antibiotic consumption 6 months before inclusion HIV positive or AIDS Allergic reactions to macrolides and specifically to azithromycin Periodontal treatment 6 months before inclusion
Facility Information:
Facility Name
Universidad Del Valle
City
Cali
Country
Colombia

12. IPD Sharing Statement

Learn more about this trial

STUDY ON THE EFFECTS OF PERIODONTAL TREATMENT ALONG WITH THE USE OF ANTIBIOTICS OVER HIGH SENSITIVE C-REACTIVE PROTEIN. RANDOMIZED CONTROLLED CLINICAL TRIAL.

We'll reach out to this number within 24 hrs